KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Interest Expenses (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Interest Expenses for 7 consecutive years, with $10.4 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 8.41% to $10.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.6 million through Dec 2025, down 19.49% year-over-year, with the annual reading at $42.6 million for FY2025, 19.49% down from the prior year.
  • Interest Expenses hit $10.4 million in Q4 2025 for GoodRx Holdings, down from $10.8 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $14.8 million in Q4 2023 to a low of $5.9 million in Q1 2022.
  • Historically, Interest Expenses has averaged $10.5 million across 5 years, with a median of $10.8 million in 2025.
  • Biggest five-year swings in Interest Expenses: crashed 31.64% in 2021 and later skyrocketed 123.77% in 2023.
  • Year by year, Interest Expenses stood at $5.9 million in 2021, then skyrocketed by 102.05% to $11.9 million in 2022, then grew by 24.26% to $14.8 million in 2023, then dropped by 23.37% to $11.4 million in 2024, then decreased by 8.41% to $10.4 million in 2025.
  • Business Quant data shows Interest Expenses for GDRX at $10.4 million in Q4 2025, $10.8 million in Q3 2025, and $10.7 million in Q2 2025.